x

Search for a clinical trial

* (*) mandatory field

A Phase III Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Dystrophinopathy - UK

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • Pr Kate BUSHBY
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine
  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Trust
  • Central Parkway
  • NEWCASTLE UPON TYNE NE1 3BZ
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)191 241 8640
  • Fax  : -
  • Website
  • Contact secretary  :
  • Investigator of clinical trial

  • Dr Michela GUGLIERI
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine
  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Trust
  • Central Parkway
  • NEWCASTLE UPON TYNE NE1 3BZ
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)191 241 8640
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: August 2017

Part of a multinational clinical trial

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.